메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

LuX-Valve Plus Approved for Hong Kong-Macao Medicine and Equipment Connect

BEIJING, Oct. 9, 2025 -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with comprehensive structural heart disease interventional solutions, recently announced that LuX-Valve Plus transjugular tricuspid valve replacement system, the product of its subsidiary Jenscare Scientific (Netherlands) B.V., has been officially approved to be included in the Medical Device Catalog of Hong Kong-Macao Medicine and Equipment Connect, enabling commercial clinical application in designated medical institutions in mainland of
- 김갑성 기자
- 2025-10-09 21:00
LEIFRAS Co., Ltd. Announces Listing on the Nasdaq Capital Market in the U.S.

TOKYO, Oct. 9, 2025 -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement, today announced that its American Depository Shares ("ADSs") will commence trading on the Nasdaq Capital Market under the ticker symbol "LFS" on October 9, 2025. A registration statement on Form F-1 (File Number: 333-283712), as amended, relating to this offering was filed with the U.S. Securities and Exchange Commission (the "SEC") and was declared effective by the
- 황정호 기자
- 2025-10-09 21:00
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission

[ 메디채널 김갑성 기자 ] The phase 3 clinical trial of HANSIZHUANG for perioperative gastric cancer treatment met its EFS primary endpoint, supporting an early New Drug Application (NDA) submission World-first regimen in gastric cancer that replaces adjuvant chemotherapy with mono-immunotherapy in the perioperative setting The ASTRUM-006 study demonstrated a significant improvement in event-free survival (EFS) and achieved a more than threefold higher pathological complete response (pCR) rate compared with the control arm, unlocking the potential for a cure SHANGHAI, Oct. 9, 2025 -- Sha
- 김갑성 기자
- 2025-10-09 20:50
Field Medical First-in-Human 6-Month Data Selected for Late-Breaking Clinical Trial at VT Symposium 2025

Three sessions feature new outcomes, a live case, and preclinical research with the FieldForce™ Ablation System. CARDIFF-BY-THE-SEA, Calif., and PHILADELPHIA, Oct. 9, 2025 -- Field Medical, Inc., a leader in pulsed field ablation (PFA) technology for ventricular tachycardia (VT), today announced its participation at the 20th Annual International Symposium on Ventricular Arrhythmias (VT Symposium), taking place Oct. 10 –11 in Philadelphia. Field Medical will be featured across three sessions, including first-in-human six-month outcomes from its FieldForce™ Ablatio
- 김갑성 기자
- 2025-10-09 20:33
DBS recognised as Safest Bank in Asia yet again

Recognised by Global Finance as Asia's Safest Bank for the 17th year and ranked 2nd globally among the 50 Safest Commercial Banks SINGAPORE, Oct. 9, 2025 -- DBS announced today that it has once again been named "Safest Bank in Asia" in 2025, marking its 17th consecutive year receiving this distinguished recognition. The bank also retained its position at 2nd in the 'World's 50 Safest Commercial Banks' list. The rankings underscore DBS' solid financial performance, strong risk management and governance, as well as robust balance sheet. The Global F
- 황정호 기자
- 2025-10-09 20:20
K11 ECOAST Art and Cultural District by the Sea Unveils Coastal Cultural Event Featuring Local and Western Experiences

SHENZHEN, China, Oct. 9, 2025 -- In the context of the accelerating integration of culture and tourism in the Greater Bay Area (GBA), K11 ECOAST Art and Cultural District by the Sea is presenting a multi-dimensional immersive cultural experience starting from National Day holiday. Under the guidance of the Nanshan District Culture, Radio, Television, Tourism and Sports Bureau, K11 ECOAST focuses on Sino-Western artistic dialogue, intangible cultural heritage (ICH) revitalization, and local intellectual property (IP) innovation. This initiative aims to create new cultural consumption scenarios
- 김장윤(JASON KIM) 기자
- 2025-10-09 20:17
Saudi Arabia Accelerates Its Industrial Transformation Through the Fourth Industrial Revolution

RIYADH, Saudi Arabia, Oct. 9, 2025 -- Saudi Arabia's industrial sector is entering a new era of transformation, driven by innovation, advanced technology, and sustainable growth. Under the leadership of the Ministry of Industry and Mineral Resources, this shift supports the ambitions of Saudi Vision 2030 to diversify the economy and position industry as a key engine of development through investment attraction, infrastructure advancement, and talent empowerment. At the center of this transformation lies the Fourth Industrial Revolution (4IR), which is reshaping manufacturing th
- 황정호 기자
- 2025-10-09 20:12
Starburst Unveils AI-Ready Data Platform to Power the Agentic Workforce

[ 메디채널 김장윤(JASON KIM) 기자 ] The first lakehouse platform to unify AI agents, governed data products, and metadata, enabling context-aware enterprises to scale AI with confidence NEW YORK, Oct. 9, 2025 -- Starburst, the data platform for apps and AI, today announced at AI & Datanova, a new set of capabilities designed to operationalize the Agentic Workforce—a paradigm where humans and AI agents collaborate seamlessly across workflows to reason, decide, and act faster and with confidence. With new, built-in support for model-to-data architectures, multi-agent interoperability, and a
- 김장윤(JASON KIM) 기자
- 2025-10-09 20:00
Health In Tech Showcases Enhanced eDIYBS Platform at SIIA 2025, Accelerating Broker Growth and Market Reach

STUART, Fla.Oct. 9, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, will showcase its groundbreaking Enhanced Do It Yourself Benefit System (eDIYBS) at the upcoming SIIA National Conference, being held October 12–14, 2025 at the JW Marriott Desert Ridge in Phoenix, Arizona. Recently upgraded in September 2025, the platform now supports mid- and large-sized employers (150+ employees), significantly expanding HIT's addressable market. Health In Tech's presence at SIIA represents a strategic opportunity to expa
- 황정호 기자
- 2025-10-09 19:30
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™

ExellenS TM applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed ExellenS TM combines the company's commitment to operational excellence with its core manufacturing competencies, guided by standardization, simplification, and scalability ExellenS TM delivers faster tech transfers, rapid approvals, predictable outcomes, and global flexibility for clients INCHEON, South Korea, Oct. 9, 2025 -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today unveiled Exe
- 김갑성 기자
- 2025-10-09 19:00

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-10-15_WED

Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress 00:00

2025-10-14_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 15일 01시 40분